Congratulate that the Bigfish Novel Coronavirus (SARS-CoV-2）Antigen Rapid Test (Colloidal Gold）has been awarded the European CE certificate

At present, the epidemic has fluctuated repeatedly and the virus has frequently mutated. According to statistics released on November 10, the number of COVID-19 cases worldwide has increased by more than 540,000, and the cumulative number of confirmed cases has exceeded 250 million. COVID-19 is taking an unprecedented toll on the health and economies of people around the world. Overcoming the epidemic at an early date and restoring economic growth are the top priority of the international community. Judging from overseas epidemic prevention, there is a broad market demand for COVID-19 antigen products.

Recently, Novel Coronavirus(SARS-CoV-2）Antigen Rapid Test(Colloidal Gold） by Bigfish was granted the CE certificate of the European Union. After obtaining the CE certification, the product can be sold in the EU countries and countries that recognize the CE certification, further enriching the company’s product line.

Novel Coronavirus (SARS-CoV-2）Antigen Rapid Test(Colloidal Gold）by Bigfish is easy to operate without instruments,and fast to detect. The results are available within 15 minutes. It can also identify acute or early infection.

Facing novel coronavirus infection, Bigfish will focus on core technologies with rigorous and realistic working style. We will provide excellent products and services to contribute for global epidemic prevention and control on human health.